| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
14,800,000 |
| Market
Cap: |
318.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.53 - $74.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Semler Scientific provides technology solutions for healthcare providers. Co. develops, manufactures and markets products and services that assist its customers in evaluating and treating diseases. Co. markets a vascular testing product, QuantaFlo, which is an in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition. Co. also has an arrangement for the U.S., including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood glucose levels in insulin-dependent patients with Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,896,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
28,604 |
28,604 |
128,604 |
200,265 |
| Total Sell Value |
$873,566 |
$873,566 |
$6,938,372 |
$9,448,801 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
3 |
8 |
| End Date |
2025-08-21 |
2025-05-20 |
2024-11-19 |
2023-11-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Murphy-Chutorian Douglas |
CEO, interim CFO and Director |
• • – |
2025-11-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
54,594 |
241,303 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO, interim CFO and Director |
• • – |
2025-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
54,594 |
0 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO, interim CFO and Director |
• • – |
2025-11-17 |
4 |
S |
$20.09 |
$1,422,608 |
D/D |
(70,406) |
54,594 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO, interim CFO and Director |
• • – |
2025-11-17 |
4 |
OE |
$2.23 |
$278,750 |
D/D |
125,000 |
125,000 |
|
- |
|
| Murphy-Chutorian Douglas |
Chief Executive Officer |
• • – |
2025-08-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
31,396 |
186,709 |
|
- |
|
| Murphy-Chutorian Douglas |
Chief Executive Officer |
• • – |
2025-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
31,396 |
0 |
|
- |
|
| Murphy-Chutorian Douglas |
Chief Executive Officer |
• • – |
2025-08-25 |
4 |
S |
$30.54 |
$873,566 |
D/D |
(28,604) |
31,396 |
|
27% |
|
| Murphy-Chutorian Douglas |
Chief Executive Officer |
• • – |
2025-08-25 |
4 |
OE |
$2.56 |
$153,600 |
D/D |
60,000 |
60,000 |
|
- |
|
| Cormier Renae |
Chief Financial Officer |
• – – |
2025-06-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,746 |
3,746 |
|
- |
|
| Cormier Renae |
Chief Financial Officer |
• – – |
2025-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,746 |
0 |
|
- |
|
| Cormier Renae |
Chief Financial Officer |
• – – |
2025-06-11 |
4 |
OE |
$30.48 |
$114,178 |
D/D |
3,746 |
3,746 |
|
- |
|
| Semler Eric |
Director |
– • – |
2025-06-11 |
4 |
OE |
$23.32 |
$157,410 |
D/D |
6,750 |
636,346 |
|
- |
|
| Semler Eric |
Director |
– • – |
2024-12-16 |
4 |
OE |
$23.32 |
$183,645 |
D/D |
7,875 |
629,596 |
|
- |
|
| Chang William H |
Director |
– • – |
2024-12-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,735 |
439,660 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
55,000 |
155,313 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
55,000 |
0 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-11 |
4 |
S |
$59.08 |
$1,556,123 |
D/D |
(25,000) |
55,000 |
|
47% |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-11 |
4 |
OE |
$3.44 |
$51,314 |
D/D |
14,917 |
80,000 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-10 |
4 |
S |
$59.74 |
$4,508,683 |
D/D |
(75,000) |
65,083 |
|
43% |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-12-10 |
4 |
OE |
$3.44 |
$481,886 |
D/D |
140,083 |
140,083 |
|
- |
|
| Chang William H |
Director |
– • • |
2024-11-07 |
4/A |
GA |
$0.00 |
$0 |
I/I |
1,318 |
445,895 |
|
- |
|
| Chang William H |
Director |
– • • |
2024-11-07 |
4/A |
GD |
$0.00 |
$0 |
D/D |
1,318 |
0 |
|
- |
|
| Chang William H |
Director |
– • • |
2024-11-07 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,318 |
1,318 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-11-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
50,000 |
100,313 |
|
- |
|
| Murphy-Chutorian Douglas |
CEO |
• • – |
2024-11-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
0 |
|
- |
|
186 Records found
|
|
Page 1 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.49 (7.44%) 
